Total Payments
$12,435
2021 Payments
$182.69
Companies
9
Transactions
37
Medicare Patients
9,582
Medicare Billing
$720,042
Payment Breakdown by Category
Consulting$11,725 (94.3%)
Food & Beverage$709.51 (5.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,725 | 1 | 94.3% |
| Food and Beverage | $709.51 | 36 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Research Ltd | $11,725 | 1 | $0 (2017) |
| Aerie Pharmaceuticals, Inc. | $223.29 | 12 | $0 (2021) |
| Allergan, Inc. | $183.09 | 9 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $95.79 | 5 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $92.33 | 5 | $0 (2021) |
| Sight Sciences, Inc. | $44.83 | 1 | $0 (2019) |
| Sun Pharmaceutical Industries Inc. | $39.03 | 2 | $0 (2019) |
| Shire North American Group Inc | $17.62 | 1 | $0 (2017) |
| Glaukos Corporation | $13.53 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $182.69 | 10 | Aerie Pharmaceuticals, Inc. ($119.48) |
| 2020 | $109.59 | 5 | Aerie Pharmaceuticals, Inc. ($62.87) |
| 2019 | $197.21 | 9 | Sight Sciences, Inc. ($44.83) |
| 2018 | $115.97 | 6 | Allergan Inc. ($61.61) |
| 2017 | $11,829 | 7 | Alcon Research Ltd ($11,725) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/11/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Glaucoma | ||||||
| 09/13/2021 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Glaucoma | ||||||
| 08/23/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/30/2021 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Glaucoma | ||||||
| 05/19/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Glaucoma | ||||||
| 04/21/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), ZYLET, BESIVANCE | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Ophthalmology | ||||||
| 03/10/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Glaucoma | ||||||
| 03/04/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: Glaucoma | ||||||
| 02/04/2021 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Glaucoma | ||||||
| 12/11/2020 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Glaucoma | ||||||
| 10/27/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/28/2020 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Glaucoma | ||||||
| 05/08/2020 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Glaucoma | ||||||
| 11/05/2019 | Aerie Pharmaceuticals, Inc. | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Glaucoma | ||||||
| 10/25/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug), VYZULTA | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/10/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/02/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/07/2019 | Sight Sciences, Inc. | OMNI (Device) | Food and Beverage | In-kind items and services | $44.83 | General |
| Category: Ophthalmology | ||||||
| 05/07/2019 | Aerie Pharmaceuticals, Inc. | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Glaucoma | ||||||
| 02/18/2019 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/14/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/16/2019 | Sun Pharmaceutical Industries Inc. | XELPROS (Drug) | Food and Beverage | Cash or cash equivalent | $22.53 | General |
| Category: Ophthalmology | ||||||
| 12/19/2018 | Sun Pharmaceutical Industries Inc. | XELPROS (latanoprost ophthalmic emulsion) 0.005% (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 1,710 | 2,337 | $704,422 | $141,010 |
| 2022 | 6 | 1,989 | 2,438 | $693,334 | $137,123 |
| 2021 | 10 | 2,746 | 3,654 | $538,296 | $210,811 |
| 2020 | 8 | 3,137 | 4,153 | $511,554 | $231,098 |
Total Patients
9,582
Total Services
12,582
Medicare Billing
$720,042
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 536 | 1,050 | $409,500 | $88,391 | 21.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 402 | 435 | $123,105 | $17,800 | 14.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 209 | 250 | $67,250 | $16,868 | 25.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 444 | 467 | $80,791 | $10,960 | 13.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 70 | 82 | $11,480 | $3,596 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 53 | $12,296 | $3,395 | 27.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 544 | 721 | $281,190 | $64,124 | 22.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 432 | 633 | $170,277 | $34,714 | 20.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 524 | 572 | $161,876 | $24,845 | 15.3% |
| 92133 | Imaging of optic nerve | Office | 2022 | 399 | 413 | $64,015 | $9,066 | 14.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 68 | 76 | $10,640 | $2,732 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 23 | $5,336 | $1,643 | 30.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 662 | 1,315 | $153,808 | $81,044 | 52.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 600 | 612 | $107,618 | $50,879 | 47.3% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 583 | 658 | $84,203 | $29,533 | 35.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 282 | 406 | $27,740 | $16,474 | 59.4% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 495 | 531 | $58,875 | $13,964 | 23.7% |
| 65855 | Laser repair to improve eye fluid flow, 1 or more sessions | Office | 2021 | 47 | 49 | $63,700 | $8,051 | 12.6% |
| 66821 | Removal of recurring cataract in lens capsule using laser | Office | 2021 | 14 | 15 | $15,000 | $4,027 | 26.8% |
| 66761 | Creation of eye fluid drainage tracts in iris using laser, per session | Office | 2021 | 12 | 17 | $21,112 | $3,705 | 17.5% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 26 | 26 | $4,680 | $2,614 | 55.8% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Office | 2021 | 25 | 25 | $1,560 | $519.34 | 33.3% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 696 | 1,454 | $145,400 | $88,088 | 60.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 709 | 716 | $107,400 | $60,632 | 56.5% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 677 | 744 | $81,184 | $33,403 | 41.1% |
About Dr. Stephen Goode, M.D
Dr. Stephen Goode, M.D is a Glaucoma Specialist healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215914478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Goode, M.D has received a total of $12,435 in payments from pharmaceutical and medical device companies, with $182.69 received in 2021. These payments were reported across 37 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($11,725).
As a Medicare-enrolled provider, Goode has provided services to 9,582 Medicare beneficiaries, totaling 12,582 services with total Medicare billing of $720,042. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Glaucoma Specialist
- Other Specialties Specialist
- Location Fort Worth, TX
- Active Since 12/29/2005
- Last Updated 07/08/2025
- Taxonomy Code 207WX0009X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215914478
Products in Payments
- LUMIGAN (Drug) $160.11
- rocklatan (Drug) $111.37
- rhopressa (Drug) $70.98
- SIMBRINZA (Biological) $59.44
- BESIVANCE (Drug) $54.41
- OMNI (Device) $44.83
- Rocklatan (Drug) $40.94
- VYZULTA (Drug) $23.23
- COMBIGAN (Drug) $22.98
- TRAVATAN Z (Drug) $22.89
- XELPROS (Drug) $22.53
- XIIDRA (Drug) $17.62
- XELPROS (latanoprost ophthalmic emulsion) 0.005% (Drug) $16.50
- LOTEMAX SM (Drug) $14.69
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $13.53
- DUREZOL (Drug) $13.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.